Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Eczema

Severe eczema linked to increased risk of cardiovascular disease, large UK study finds

Severe and predominantly active atopic eczema are associated with an increased risk of cardiovascular outcomes, according to research published in the British Medical Journal (online, 23 May 2018)[1].

In the largest study involving data from almost 2million people to assess the association between atopic eczema and major cardiovascular events, researchers scoured UK electronic health records from the Clinical Practice Research Datalink, Hospital Episode Statistics, and data from the Office for National Statistics from between 1998 and 2015.

In those with atopic eczema, the researchers found evidence of a 10–20% increased hazard for non-fatal cardiovascular outcomes, including heart failure, atrial fibrillation and stroke.

Patients with severe atopic eczema were found to have a 20% increase in the risk of stroke and a 40% to 50% increased risk of myocardial infarction, unstable angina, atrial fibrillation and cardiovascular death, and a 70% increased risk of heart failure.

Patients with the most active atopic eczema were also at a greater risk of cardiovascular outcomes.

“It’s important to highlight the absolute risk of people with eczema experiencing a cardiovascular event is low,” said Sinead Langan, Wellcome Trust Senior Fellow at the London School of Hygiene & Tropical Medicine and study lead investigator.

“However, with heart and circulatory disease causing more than a quarter of all deaths in the UK, it’s important we explore all potential risk factors.”

In the paper, the authors recommended that consideration should be given to cardiovascular disease prevention strategies for patients with severe and more active atopic eczema including awareness of and screening for conventional cardiovascular risk factors by those providing clinical care.

“Current biological treatments for atopic eczema have the potential to greatly change care for those with challenging eczema … the next objective will be to reduce the risk of cardiovascular outcomes,” the authors concluded.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20204904

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Pathology and Therapeutics for Pharmacists

    Pathology and Therapeutics for Pharmacists

    An practical, integrated approach to the pathophysiological and pharmacotherapeutic principles underlying the treatment of disease.

    £54.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Lecture Notes in Pharmacy Practice

    Lecture Notes in Pharmacy Practice

    A comprehensive study guide which summarises the basic principles in pharmacy practice. Clear, bulleted information for quick reference.

    £43.00Buy now
  • MCQs in Pharmacy Practice

    MCQs in Pharmacy Practice

    A study aid with 800 MCQs. Assess your knowledge, analytical skills, and ability to apply this knowledge base in clinical practice.

    £25.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Eczema on the skin

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.